HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $415,830 | -25.7% | 4,642 | -47.6% | 0.03% | +68.8% |
| Q1 2022 | $560,000 | -40.6% | 8,857 | -33.7% | 0.02% | -33.3% |
| Q3 2021 | $943,000 | -9.8% | 13,352 | -14.9% | 0.02% | -22.6% |
| Q2 2021 | $1,046,000 | -58.9% | 15,693 | -31.5% | 0.03% | -52.3% |
| Q1 2021 | $2,542,000 | +23.5% | 22,897 | +32.1% | 0.06% | +25.0% |
| Q4 2020 | $2,058,000 | +350.3% | 17,328 | +230.9% | 0.05% | +136.4% |
| Q3 2020 | $457,000 | +7.8% | 5,237 | +10.7% | 0.02% | -4.3% |
| Q2 2020 | $424,000 | +3161.5% | 4,731 | +4162.2% | 0.02% | – |
| Q4 2019 | $13,000 | -89.7% | 111 | -97.5% | 0.00% | -100.0% |
| Q2 2016 | $126,000 | +75.0% | 4,362 | +171.8% | 0.02% | +80.0% |
| Q1 2015 | $72,000 | – | 1,605 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |